Related Experiment Video

Updated: Jun 26, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

Surabhi Dangi-Garimella1, Jieun Yun, Eva M Eves

  • 1Ben May Department for Cancer Research, Gordon Center for Integrative Sciences, University of Chicago, IL 60637, USA.

The EMBO Journal
|January 21, 2009
PubMed

Insights

Raf kinase inhibitory protein (RKIP) suppresses breast cancer metastasis by inhibiting MAPK signaling, which enhances let-7 microRNA activity. This pathway reduces tumor cell invasion and bone metastasis, highlighting RKIP as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Raf kinase inhibitory protein (RKIP) is known to negatively regulate key signaling pathways like MAPK.
  • RKIP's role as a metastasis suppressor in prostate cancer is established, but its mechanism in breast cancer remains unclear.
  • Metastasis involves complex cellular processes including invasion, intravasation, and colonization of distant sites.

Purpose of the Study:

  • To elucidate the mechanism by which RKIP suppresses breast cancer metastasis.
  • To investigate the role of RKIP in regulating cancer cell invasion and bone metastasis.
  • To identify the specific signaling cascade modulated by RKIP in breast cancer.

Main Methods:

  • Utilized an orthotopic murine model to study breast tumor cell intravasation and bone metastasis.
  • Investigated the impact of RKIP on MAPK signaling and downstream gene transcription (LIN28, Myc).
  • Assessed the role of let-7 microRNA processing and its targets (HMGA2, Snail) in metastasis.

Main Results:

  • RKIP inhibits breast cancer cell invasion, intravasation, and bone metastasis in vivo.
  • RKIP suppresses MAPK signaling, leading to reduced Myc-mediated LIN28 transcription.
  • LIN28 depletion and increased let-7 expression suppress metastasis, while LIN28 overexpression restores it.

Conclusions:

  • RKIP acts as a metastasis suppressor in breast cancer via a MAPK-Myc-LIN28-let-7 signaling axis.
  • This pathway involves the regulation of stem cell genes LIN28 and Myc, underscoring RKIP's significance.
  • RKIP represents a promising therapeutic target for inhibiting cancer metastasis.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...